Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,572 across all filing types
Latest filing 2021-06-03 Merger & Acquisition
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
425 Filing
Merger & Acquisition Classification · 95% confidence The document is filed by Illumina, Inc. pursuant to Rule 425 under the Securities Act of 1933, which is a communication related to a merger transaction. It discusses the Illumina-Grail merger, regulatory scrutiny, and litigation related to the merger. The document references filings such as Form S-4 and registration statements related to the transaction. The content is a communication about the merger and related regulatory and legal developments, not the merger agreement or proxy statement itself. It is a type of merger communication filed under Rule 425, which is typically classified under Merger & Acquisition (MA) filings. The document is substantive and over 13,000 characters, containing detailed information about the merger and regulatory environment, fitting the MA category rather than a simple announcement or regulatory filing.
2021-06-03 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 26, 2021, by Illumina, Inc. It reports the submission of matters to a vote of security holders at the 2021 annual meeting, including election of directors, ratification of the independent auditor, and advisory approval of executive compensation. The content is focused on official voting results from the annual meeting. There is no detailed financial data or full report content, but rather the official voting outcomes. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4710 characters, which is sufficient to include detailed voting results rather than just an announcement of a report publication. Therefore, the correct classification is DVA with high confidence.
2021-05-28 English
PRIMARY DOCUMENT
Director's Dealing
2021-05-27 English
PRIMARY DOCUMENT
Director's Dealing
2021-05-27 English
PRIMARY DOCUMENT
Director's Dealing
2021-05-27 English
PRIMARY DOCUMENT
Director's Dealing
2021-05-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.